Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical …
MJ Domanski, DV Exner, CB Borkowf, NL Geller… - Journal of the American …, 1999 - jacc.org
OBJECTIVES Estimate the effect of angiotensin converting enzyme (ACE) inhibitors on the
risk of sudden cardiac death (SCD) following myocardial infarction (MI). BACKGROUND …
risk of sudden cardiac death (SCD) following myocardial infarction (MI). BACKGROUND …
Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study
AS Hall, GD Murray, SG Ball - The Lancet, 1997 - thelancet.com
Summary Background In the Acute Infarction Ramipril Efficacy (AIRE) Study, the effect of
angiotensin-converting-enzyme (ACE) inhibition on the survival of patients with clinical heart …
angiotensin-converting-enzyme (ACE) inhibition on the survival of patients with clinical heart …
ACE inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials
R Latini, AP Maggioni, M Flather, P Sleight, G Tognoni - Circulation, 1995 - Am Heart Assoc
Experimental evidence for the beneficial effects on heart failure of chronic treatment with
ACE inhibitors accumulated from early 1980 in experimental models of LV dysfunction …
ACE inhibitors accumulated from early 1980 in experimental models of LV dysfunction …
Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction: the healing and early afterload reducing therapy trial
MA Pfeffer, SC Greaves, JMO Arnold, RJ Glynn… - Circulation, 1997 - Am Heart Assoc
Background Although ACE inhibitor therapy has been shown to reduce mortality in patients
with acute myocardial infarction (MI), the optimal dose and the timing of its initiation have not …
with acute myocardial infarction (MI), the optimal dose and the timing of its initiation have not …
[HTML][HTML] Angiotensin‐converting enzyme inhibitors
JL Izzo Jr, MR Weir - The Journal of Clinical Hypertension, 2011 - ncbi.nlm.nih.gov
• The most familiar angiotensin-converting enzyme subtype, angiotensin-converting enzyme-
1 (kininase II), cleaves the vasoconstrictor octapeptide angiotensin II from its inactive …
1 (kininase II), cleaves the vasoconstrictor octapeptide angiotensin II from its inactive …
Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update
JC Song, CM White - Clinical pharmacokinetics, 2002 - Springer
The angiotensin converting enzyme (ACE) inhibitors are widely used in the management of
essential hypertension, stable chronic heart failure, myocardial infarction (MI) and diabetic …
essential hypertension, stable chronic heart failure, myocardial infarction (MI) and diabetic …
Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival …
KN Nguyen, I Aursnes, J Kjekshus - The American journal of cardiology, 1997 - Elsevier
The use of angiotensin-converting enzyme (ACE) inhibitors early after an acute myocardial
infarction to reduce mortality has been studied in several trials with inconsistent results …
infarction to reduce mortality has been studied in several trials with inconsistent results …
Guías de actuación clínica de la Sociedad Española de Cardiología en el infarto agudo de miocardio
F Arós, Á Loma-Osorio, Á Alonso, JJ Alonso… - Revista española de …, 1999 - Elsevier
En los últimos años han surgido nuevas posibilidades en el diagnóstico y tratamiento del
infarto agudo de miocardio con elevación del segmento ST y sus complicaciones. Además …
infarto agudo de miocardio con elevación del segmento ST y sus complicaciones. Además …
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic …
R Latini, G Tognoni, AP Maggioni, MG Franzosi… - Journal of the American …, 2000 - jacc.org
OBJECTIVES We sought to determine whether the clinical effects of early angiotensin-
converting enzyme (ACE) inhibitor (ACEi) treatment for acute myocardial infarction (MI) are …
converting enzyme (ACE) inhibitor (ACEi) treatment for acute myocardial infarction (MI) are …
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term …
C Borghi, E Ambrosioni - American heart journal, 2003 - Elsevier
Background Angiotensin-converting enzyme (ACE) inhibitors have been reported to be
effective in placebo-controlled trials in various subsets of patients with acute myocardial …
effective in placebo-controlled trials in various subsets of patients with acute myocardial …